Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 11  |  Issue : 3  |  Page : 295-303

Safety and antioxidant potential of traditional thai poly-herbal tea “phy-blica-d” used as a rejuvenation formula


1 Department of Physiology, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, Thailand
2 Faculty of Traditional Thai Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
3 Faculty of Traditional Thai Medicine; Natural Product Research Center of Excellence, Prince of Songkla University, Hat Yai, Songkhla, Thailand
4 Department of Food Science and Nutrition, Faculty of Science and Technology, Prince of Songkla University, Pattani Campus, Rusamilae, Pattani, Thailand

Correspondence Address:
Prof. Sasitorn Chusri
Faculty of Traditional Thai Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pr.pr_5_19

Rights and Permissions

Background: The rising popularity of phytonutrient consumption may be due to a vast number of scientific studies that have revealed their health benefits; however, concerns regarding the medical safety of herbal-based products are increasing. Phy-Blica-O is Phyllanthus emblica- based herbal tea used in Thai traditional medicine as a rejuvenating remedy. However, its consumption has been limited due to its strong bitter taste with unpleasant odor. Objective: The objective of this study is to evaluate the safety and antioxidant potential of Phy-Blica-D, the modified formula of Phy-Blica-O which gave high sensory acceptability scores. Materials and Methods: Subacute toxicity studies of Phy-Blica-D infusion was conducted by repeated oral administration of the extract at doses of 5, 50, and 300 mg/kg/day in Sprague-Dawley rats. Results: The formula exhibited antioxidant activity with an IC50of 0.243 ± 0.006, 0.486 ± 0.002 and 0.108 ± 0.004 mg/mL using 1,1-diphenyl-2-picrylhydrazyl, 2,20-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid and metal chelating assays, respectively. There was no significant treatment-related toxicity as indicated by clinical signs, body weight, food consumption, serum biochemical and hematological parameters, organ weight, and histopathological examination of the animals treated with Phy-Blica-D infusion. These results suggest that the oral no-observed-adverse-effect-level of Phy-Blica-D extract is >300 mg/kg body weight/day, or ~3.7 L/kg body weight/day for both sexes. The calculated human equivalent dose value is 48.39 mg/kg/day, or ~600 mL/kg body weight/day. There were no target organs affected. Conclusion: This study demonstrates that Phy-Blica-D infusion can be regarded as safe and could potentially be used as a functional ingredient to reduce oxidative stress in non-communicable diseases.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed133    
    Printed2    
    Emailed0    
    PDF Downloaded1    
    Comments [Add]    

Recommend this journal